Skip to main content

ÍS
EN

Forsíða

Forsíða

Sigurdís Haraldsdóttir - Associate Professor

Sigurdís Haraldsdóttir

–

Heilbrigðisvísindasvið

Sigurdís Haraldsdóttir

Associate Professor

Location
LSH - Hringbraut
Email
sigurdis [at] hi.is

Unit
Faculty of Medicine

Published works

2023

Metachronous Colorectal Cancer in Icelandic MSH6 and PMS2 Lynch Syndrome Carriers in 1955–2017: A Population-based StudyGastroenterology

2022

Universal tumor screening in a population with MSH6- and PMS2-associated Lynch syndromeGenetics in Medicine

2021

Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal CancerOncologist
Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at StanfordJNCI Cancer Spectrum
Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic CancerJCO oncology practice

2020

Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at StanfordJNCI Cancer Spectrum
Profiling diverse sequence tandem repeats in colorectal cancer reveals co-occurrence of microsatellite and chromosomal instability involving Chromosome 8bioRxiv
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for ImmunotherapyOncologist
Germline testing for patients with BRCA1/2 mutations on somatic tumor testingJNCI Cancer Spectrum
An amino-terminal BRAF deletion accounting for acquired resistance to RAF/EGFR inhibition in colorectal cancerCold Spring Harbor Molecular Case Studies

2019

Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndromeJournal of Medical Genetics
Microsatellite instability and adjuvant chemotherapy in stage II colon cancerAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Comparison of definitive chemoradiation with 5-fluorouracil versus capecitabine in anal cancerJournal of Gastrointestinal Oncology
Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndromeBMJ Open Gastroenterology
Genetic/Familial high-risk assessment: Colorectal, version 2.2019 featured updates to the NCCN guidelinesJNCCN Journal of the National Comprehensive Cancer Network

2018

Promising New Agents for Colorectal CancerCurrent Treatment Options in Oncology
Phase I trial of dabrafenib and pazopanib in BRAF mutated advanced malignanciesJCO Precision Oncology
Management of Borderline Resectable Pancreatic CancerInternational Journal of Radiation Oncology Biology Physics
Tumor Molecular Testing Guides Anti-PD-1 Therapy and Provides Evidence for Pathogenicity of Mismatch Repair VariantsOncologist
Targeting BRAF mutations in high-grade neuroendocrine carcinoma of the colonJNCCN Journal of the National Comprehensive Cancer Network
Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndromeHuman Pathology
The risk of developing a mismatch repair deficient colorectal cancer after undergoing cholecystectomyScandinavian Journal of Gastroenterology

2017

Conversion Therapy for Initially Borderline/Unresectable Metastases in Colon Cancer: What Is the Best Neoadjuvant Chemotherapy?Current Colorectal Cancer Reports
Microsatellite instability testing using next-generation sequencing data and therapy implicationsJCO Precision Oncology
Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2Nature Communications

2016

Radiation recall dermatitis with concomitant dabrafenib and pazopanib therapyJAMA Dermatology
Discordant mismatch repair protein immunoreactivity in lynch syndrome-associated neoplasms: A recommendation for screening synchronous/metachronous neoplasmsAmerican Journal of Clinical Pathology
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair GenesGastroenterology
Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasisFamilial Cancer
Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognosesGenetics in Medicine

2015

Circulating tumor markers in patients with neuroendocrine tumors-a clinical perspectiveInternational Journal of Endocrine Oncology

2014

Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutationsGastroenterology
New era for treatment in differentiated thyroid cancerThe Lancet
How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?Current Colorectal Cancer Reports
An update on clinical trials of targeted therapies in thyroid cancerCurrent Opinion in Oncology
Prostate cancer incidence in males with Lynch syndromeGenetics in Medicine

2013

What is the optimal neo-adjuvant treatment for liver metastasis?Therapeutic Advances in Medical Oncology
Case of sorafenib-induced thyroid stormJournal of Clinical Oncology
Integrating anti-EGFR therapies in metastatic colorectal cancerJournal of Gastrointestinal Oncology

2010

Diagnostic accuracy of 64-slice multidetector CT for detection of in-stent restenosis in an unselected, consecutive patient populationEuropean Journal of Radiology

2009

Clinical evaluation and stress test have limited value in the diagnosis of in-stent restenosisScandinavian Cardiovascular Journal

2008

Diagnostic accuracy of 64-slice computed tomography compared with coronary angiography,Greiningarhæfni 64 sneiǒa ölvusneiǒ myndatækniLaeknabladid

2004

Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitroPlanta Medica

2002

Effects of tenuiorin and methyl orsellinate from the lichen Peltigera leucophlebia on 5-/15-lipoxygenases and proliferation of malignant cell lines in vitroPhytomedicine

Keywords for Specialisation:

Molecular Cancer Genetics